Hazlett, Burt & Watson, Inc. Astrazeneca PLC Transaction History
Hazlett, Burt & Watson, Inc.
- $244 Million
- Q2 2025
A detailed history of Hazlett, Burt & Watson, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 1,899 shares of AZN stock, worth $156,363. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,899
Previous 1,923
1.25%
Holding current value
$156,363
Previous $142,000
5.63%
% of portfolio
0.05%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,451Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...